Legend Biotech Corporation Sponsored ADR (LEGN) Stock Price

28.13 ▲ +0.32 (+1.15%)
Open: 27.84 Vol: 1.71M Day's range: 27.32 - 28.97 Dec 05, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
LEGN Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL BUY BUY SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 28.32▼ 28.51▼ 28.31▼ 27.44▲ 29.22▼
MA10 28.61▼ 28.25▼ 28.05▲ 27.59▲ 30.61▼
MA20 28.60▼ 27.98▲ 27.92▲ 28.93▼ 33.48▼
MA50 28.28▼ 27.71▲ 27.59▲ 30.98▼ 34.17▼
MA100 28.02▲ 27.54▲ 28.14▼ 33.95▼ 42.18▼
MA200 27.94▲ 28.39▼ 30.06▼ 33.99▼ 48.05▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.103▼ 0.053▲ 0.060▲ 0.049▲ -0.578▼
RSI 34.231▼ 51.697▲ 53.108▲ 41.496▼ 35.687▼
STOCH 12.547▼ 86.265▲ 60.777     45.656     18.792▼
WILL %R -91.304▼ -52.174     -52.174     -50.007     -77.530▼
CCI -160.012▼ 61.245     57.683     19.976     -155.699▼
Latest Filters Detected On LEGN
▲ MACD $LEGN MACD(12,26,9) Crossed Above Signal Line Set Alert
MA $LEGN Price Crossed Above MA(13) Set Alert
Legend Biotech Corporation Sponsored ADR News
Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025
Saturday, December 06, 2025 11:11 AM
Triple-class exposed patients with three prior lines of therapy in CARTITUDE-1 and CARTITUDE-4 achieved a median PFS of 50.4 months after a single infusion of CARVYKTI® Translational analyses show str ...
Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results ...
Saturday, December 06, 2025 09:02 AM
Triple-class exposed patients with three prior lines of therapy in CARTITUDE-1 and CARTITUDE-4 achieved a median PFS of 50.4 months after a single infusion of CARVYKTI®Translational analyses show stro ...
Legend Biotech: Is Carvykti Changing Cancer Treatment Forever?
Tuesday, November 25, 2025 10:38 AM
Since there's no information about Carvykti (cilta-cel) in the 10-K, I've opened Legend's Form 20-F. According to it, cilta-cel's composition patent is set to expire in 2036, and the so-called use ...
LEGN historical stock data
date open high low close volume
05/12/25 27.84 28.97 27.32 28.13 1,711,143
04/12/25 27.82 28.96 27.38 27.81 1,491,930
03/12/25 26.54 27.84 26.54 27.75 930,925
02/12/25 26.69 27.695 26.43 26.69 1,565,033
01/12/25 27.41 27.42 26.56 26.84 1,496,467
28/11/25 27.36 27.7386 27.34 27.71 482,971
26/11/25 28.18 28.28 27.20 27.50 1,268,333
25/11/25 26.905 28.22 26.67 28.19 2,445,261
24/11/25 28.21 29.39 25.71 27.15 6,280,329
21/11/25 27.58 28.25 27.396 28.17 2,055,022
Quote Details
52wk Low:25.71
52wk High:45.297
Vol:1.71M
Avg Vol(3m):25.2M
1Y Chng:-17.46%
1M Chng:-11.71%
Add to Watch List
More Information
Index US Composite
Market Cap. 5.14B